XML 48 R36.htm IDEA: XBRL DOCUMENT
v3.25.3

Reportable Segments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Reportable Segment Financial Information | The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations. Reportable Segment Financial Information (in thousands):
| Three Months Ended September 30, 2025
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 646,309 |  |  | $ | 1,246,332 |  |  | $ | — |  |  | $ | 1,892,641 |
Cost of sales (1) | 460,061 |  |  | 746,444 |  |  | — |  |  | 1,206,505 |
Selling expense | 22,373 |  |  | 147,451 |  |  | — |  |  | 169,824 |
Segment Operating Income | 163,875 |  |  | 352,437 |  |  | — |  |  | 516,312 |
Corporate G&A | — |  |  | — |  |  | 27,932 |  |  | 27,932 |
Operating Income | 163,875 |  |  | 352,437 |  |  | (27,932) |  |  | 488,380 |
Interest expense | — |  |  | — |  |  | (22,514) |  |  | (22,514) |
Other (expense) income, net (2) | — |  |  | — |  |  | (17,901) |  |  | (17,901) |
Income before Income Taxes | $ | 163,875 |  |  | $ | 352,437 |  |  | $ | (68,347) |  |  | $ | 447,965 |
Depreciation | 14,964 |  |  | 19,409 |  |  | 1,407 |  |  | 35,780 |
Amortization | 18,711 |  |  | 48,587 |  |  | — |  |  | 67,298 |
Total depreciation and amortization | $ | 33,675 |  |  | $ | 67,996 |  |  | $ | 1,407 |  |  | $ | 103,078 |
Research, Development & Engineering costs (3) | $ | 19,995 |  |  | $ | 74,686 |  |  | $ | — |  |  | $ | 94,681 |
Assets | $ | 4,837,524 |  |  | $ | 10,717,580 |  |  | $ | 627,153 |  |  | $ | 16,182,257 |
Capital Expenditures (4) | $ | 7,929 |  |  | $ | 12,984 |  |  | $ | — |  |  | $ | 20,913 |
(1)Includes $7.8 million of acquisition-related costs. (2)Includes $12.0 million of acquisition-related costs. (3)Included in cost of sales. (4)Excludes $23.1 million of acquired capital expenditures in EIG.
| Three Months Ended September 30, 2024
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 573,976 |  |  | $ | 1,134,588 |  |  | $ | — |  |  | $ | 1,708,564 |
Cost of sales | 420,375 |  |  | 672,379 |  |  | — |  |  | 1,092,754 |
Selling expense | 22,082 |  |  | 123,246 |  |  | — |  |  | 145,328 |
Segment Operating Income | 131,519 |  |  | 338,963 |  |  | — |  |  | 470,482 |
Corporate G&A | — |  |  | — |  |  | 24,631 |  |  | 24,631 |
Operating Income | 131,519 |  |  | 338,963 |  |  | (24,631) |  |  | 445,851 |
Interest expense | — |  |  | — |  |  | (25,118) |  |  | (25,118) |
Other (expense) income, net | — |  |  | — |  |  | (1,888) |  |  | (1,888) |
Income before Income Taxes | $ | 131,519 |  |  | $ | 338,963 |  |  | $ | (51,637) |  |  | $ | 418,845 |
Depreciation | $ | 12,120 |  |  | $ | 17,123 |  |  | $ | 1,303 |  |  | $ | 30,546 |
Amortization | 16,716 |  |  | 43,105 |  |  | — |  |  | 59,821 |
Total depreciation and amortization | $ | 28,836 |  |  | $ | 60,228 |  |  | $ | 1,303 |  |  | $ | 90,367 |
Research, Development & Engineering costs (1) | $ | 17,692 |  |  | $ | 76,623 |  |  | $ | — |  |  | $ | 94,315 |
Assets | $ | 4,850,224 |  |  | $ | 9,384,031 |  |  | $ | 533,384 |  |  | $ | 14,767,639 |
Capital Expenditures | $ | 9,073 |  |  | $ | 13,622 |  |  | $ | 3,587 |  |  | $ | 26,282 |
(1)Included in cost of sales.
| Nine Months Ended September 30, 2025
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 1,853,092 |  |  | $ | 3,549,576 |  |  | $ | — |  |  | $ | 5,402,668 |
Cost of sales (1) | 1,349,981 |  |  | 2,105,662 |  |  | — |  |  | 3,455,643 |
Selling expense | 66,630 |  |  | 392,999 |  |  | — |  |  | 459,629 |
Segment Operating Income | 436,481 |  |  | 1,050,915 |  |  | — |  |  | 1,487,396 |
Corporate G&A | — |  |  | — |  |  | 82,561 |  |  | 82,561 |
Operating Income | 436,481 |  |  | 1,050,915 |  |  | (82,561) |  |  | 1,404,835 |
Interest expense | — |  |  | — |  |  | (58,364) |  |  | (58,364) |
Other (expense) income, net (2) | — |  |  | — |  |  | (22,115) |  |  | (22,115) |
Income before Income Taxes | $ | 436,481 |  |  | $ | 1,050,915 |  |  | $ | (163,040) |  |  | $ | 1,324,356 |
Depreciation | $ | 46,022 |  |  | $ | 57,296 |  |  | $ | 4,324 |  |  | $ | 107,642 |
Amortization | 72,166 |  |  | 137,338 |  |  | — |  |  | 209,504 |
Total depreciation and amortization | $ | 118,188 |  |  | $ | 194,634 |  |  | $ | 4,324 |  |  | $ | 317,146 |
Research, Development & Engineering costs (3) | $ | 62,270 |  |  | $ | 221,503 |  |  | $ | — |  |  | $ | 283,773 |
Capital Expenditures (4) | $ | 25,286 |  |  | $ | 34,653 |  |  | $ | 13,312 |  |  | $ | 73,251 |
(1)Includes $7.8 million of acquisition-related costs. (2)Includes $12.0 million of acquisition-related costs. (3)Included in cost of sales. (4)Excludes $33.9 million of acquired capital expenditures in EIG.
| Nine Months Ended September 30, 2024
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 1,734,598 |  |  | $ | 3,444,980 |  |  | $ | — |  |  | $ | 5,179,578 |
Cost of sales (1) | 1,322,180 |  |  | 2,025,680 |  |  | — |  |  | 3,347,860 |
Selling expense | 67,106 |  |  | 377,540 |  |  | — |  |  | 444,646 |
Segment Operating Income | 345,312 |  |  | 1,041,760 |  |  | — |  |  | 1,387,072 |
Corporate G&A | — |  |  | — |  |  | 76,491 |  |  | 76,491 |
Operating Income | 345,312 |  |  | 1,041,760 |  |  | (76,491) |  |  | 1,310,581 |
Interest expense | — |  |  | — |  |  | (90,962) |  |  | (90,962) |
Other (expense) income, net | — |  |  | — |  |  | (2,435) |  |  | (2,435) |
Income before Income Taxes | $ | 345,312 |  |  | $ | 1,041,760 |  |  | $ | (169,888) |  |  | $ | 1,217,184 |
Depreciation | $ | 44,802 |  |  | $ | 52,553 |  |  | $ | 4,338 |  |  | $ | 101,693 |
Amortization | 55,925 |  |  | 129,431 |  |  | — |  |  | 185,356 |
Total depreciation and amortization | $ | 100,727 |  |  | $ | 181,984 |  |  | $ | 4,338 |  |  | $ | 287,049 |
Research, Development & Engineering costs (2) | $ | 36,864 |  |  | $ | 153,576 |  |  | $ | — |  |  | $ | 190,440 |
Capital Expenditures | $ | 27,845 |  |  | $ | 36,765 |  |  | $ | 10,740 |  |  | $ | 75,350 |
(1)Includes $29.2 million in EMG for Paragon acquisition-related costs. (2)Included in cost of sales.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration